Paper · 39754757
Recent Advances in Synthetic Strategies of Glycans and their Pharmaceutical Applications.
Wang H and 3 others. Curr Med Chem, 2025. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Recent Advances in Synthetic Strategies of Glycans and their Pharmaceutical Applications. Papers, record 39754757. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39754757
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recent Advances in Synthetic Strategies of Glycans and their Pharmaceutical Applications.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Polysaccharides | Major topic |
| Humans | |
| Glycosylation | |
| Glycoproteins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 202208070019 | China Scholarship Council (CSC) | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References113
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18,788,729 | Biotin sulfone as a new tool for synthetic oligosaccharide immobilization: application to multiple analysis profiling and surface plasmonic analysis of anti-Candida albicans antibody reactivity against alpha and beta (1-->2) oligomannosides. | J Med Chem | 2008 | https://conductscience.org/library/papers/18788729 | PubMed |
| 2 | 17,619,683 | Chemoenzymatic approaches to glycoprotein synthesis. | Chem Soc Rev | 2007 | https://conductscience.org/library/papers/17619683 | PubMed |
| 3 | 36,030,632 | Protecting group principles suited to late stage functionalization and global deprotection in oligosaccharide synthesis. | Carbohydr Res | 2022 | https://conductscience.org/library/papers/36030632 | PubMed |
| 4 | 16,717,404 | Enzymatic synthesis of oligosaccharides and neoglycoconjugates. | Biosci Biotechnol Biochem | 2006 | https://conductscience.org/library/papers/16717404 | PubMed |
| 5 | 36,758,451 | Chemical synthesis of oligosaccharides and their application in new drug research. | Eur J Med Chem | 2023 | https://conductscience.org/library/papers/36758451 | PubMed |
| 6 | 20,161,474 | Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research. | Nat Chem | 2009 | https://conductscience.org/library/papers/20161474 | PubMed |
| 7 | 26,756,880 | Optimal Synthetic Glycosylation of a Therapeutic Antibody. | Angew Chem Int Ed Engl | 2016 | https://conductscience.org/library/papers/26756880 | PubMed |
| 8 | 35,182,428 | Strategies to control therapeutic antibody glycosylation during bioprocessing: Synthesis and separation. | Biotechnol Bioeng | 2022 | https://conductscience.org/library/papers/35182428 | PubMed |
| 9 | 31,978,783 | Design, synthesis and biological evaluation of new ganglioside GM3 analogues as potential agents for cancer therapy. | Eur J Med Chem | 2020 | https://conductscience.org/library/papers/31978783 | PubMed |
| 10 | 36,558,902 | The Glycosylation of Immune Checkpoints and Their Applications in Oncology. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/36558902 | PubMed |
1 to 10 of 113
See all 113 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39754757
GET https://conductscience.org/api/papers/v1/39754757/references?page=2